GUELPH, ON / ACCESSWIRE / August 25, 2021 / ZEN Graphene Options Ltd. (“ZEN” or the “Firm“) (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian, nanotechnology firm targeted on next-gen healthcare options, is happy to announce that it has made an utility to vary its classification on the TSX Enterprise Alternate (“TSXV”) from a mining issuer to an industrial, expertise, life sciences issuer.
Given the Firm’s give attention to commercializing nanotechnology-enabled, next-gen healthcare options within the areas of prevention, detection and therapy – and its work in different areas utilizing graphene compounds – the Firm believes the change in classification on the TSXV higher displays the present core enterprise of the Firm.
With a view to change its classification on the TSXV, the Firm has initiated a proper Change of Enterprise course of with the TSXV, which is topic to the approval of the TSXV and requires, amongst different issues, the approval of the Firm’s shareholders. On the Firm’s upcoming shareholder assembly on September 27th, 2021, shareholders shall be requested, amongst different issues, to approve a Change of Enterprise from the mining business phase to the economic, expertise and life sciences business phase. Info regarding the proposed change of business classification might be discovered within the Firm’s administration data round dated August 19, 2021, discovered below the Firm’s profile on SEDAR.com.
Greg Fenton, ZEN CEO commented: “ZEN’s worth proposition is derived from harnessing the potential of nanotechnology to develop and commercialize new and progressive applied sciences that enhance individuals’s lives. With our present give attention to healthcare options within the areas of prevention, detection and therapy – and a sturdy analysis pipeline – we consider now’s the suitable time to align our business classification with a very powerful drivers of shareholder worth transferring ahead.”
About ZEN Graphene Options Ltd.
ZEN is a nanotechnology firm creating and commercializing next-gen healthcare options within the areas of prevention, detection and therapy. ZEN is at present targeted on commercializing ZENGuardTM, a patent-pending coating with 99% antimicrobial exercise, together with towards COVID-19, and the potential to make use of related compounds as pharmaceutical merchandise towards infectious illnesses. The corporate additionally has an unique settlement to be the worldwide commercializing associate for a newly developed, extremely scalable, aptamer-based speedy pathogen detection expertise.
For additional data:
Greg Fenton, Chief Government Officer
Tel: 1(437) 220-8140
To search out out extra about ZEN Graphene Options Ltd., please go to our web site at www.ZENGraphene.com. A duplicate of this information launch and all materials paperwork in respect of the Firm could also be obtained on ZEN’s SEDAR profile at www.sedar.ca.
Completion of the change of classification is topic to quite a lot of circumstances, together with however not restricted to, TSXV acceptance and if relevant, disinterested shareholder approval. The place relevant, the change of classification can’t shut till the required shareholder approval is obtained. There might be no assurance that the change of classification shall be accomplished as proposed or in any respect.
Traders are cautioned that, besides as disclosed within the administration data round ready in reference to the change of classification, any data launched or acquired with respect to the change of classification will not be correct or full and shouldn’t be relied upon. Buying and selling within the securities of ZEN must be thought of extremely speculative.
The TSX Enterprise Alternate Inc. has under no circumstances handed upon the deserves of the proposed change of classification and has neither permitted nor disapproved the contents of this information launch
This information launch accommodates forward-looking statements. Since forward-looking statements tackle future occasions and circumstances, by their very nature they contain inherent dangers and uncertainties. Though ZEN believes that the assumptions and elements utilized in making ready the forward-looking data on this information launch are cheap, undue reliance shouldn’t be positioned on such data, which solely applies as of the date of this information launch, and no assurance might be provided that such occasions will happen within the disclosed time frames or in any respect. ZEN disclaims any intention or obligation to replace or revise any forward-looking data, whether or not because of new data, future occasions or in any other case, aside from as required by regulation.
Neither the TSX Enterprise Alternate nor its Regulation Companies Supplier (as that time period is outlined within the insurance policies of the TSX Enterprise Alternate) accepts accountability for the adequacy or accuracy of this launch.
SOURCE: ZEN Graphene Options Ltd.
View supply model on accesswire.com: